| Name | Title | Contact Details |
|---|
Alcero is a Verdun, QC-based company in the Software and Internet sector.
With online payments, e-store, contact management/CRM capabilities, a full suite of fundraisers, beautiful emails and newsletters, a website builder & more, MemberHub helps nonprofits and volunteer-run organizations engage their supporters, raise money...
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
OneID is an entirely new way to easily and securely sign in to websites and pay online.
ICT is one of the largest providers of technical Japanese and English speaking interpreters and translators in the USA. On-site Japanese and English interpreters and translators for some of the largest Japanese and American companies in the World.